India, April 1 -- The Government of India has issued a release:
GLP-1 medication name
Semaglutide injection
Semaglutide tablets
Liraglutide
Tirzepatide
Dulaglutide
Exenatide
Exenatide extended release
Introduction
Diabetes is a chronic disease that occurs when the pancreas does not produce adequate insulin, or when the body cannot effectively use the insulin it produces, leading to high blood sugar. If left untreated, it can lead to complications like blindness, kidney failure, heart attacks, stroke and lower limb amputation.
Insulin and glucagon are hormones produced by the pancreas that regulate blood sugar (glucose) levels. Insulin helps convert food into energy and lowers blood sugar by enabling cells to absorb glucose, while...